MRSA infections have declined in recent years, paralleling a drop in adults.
Saudi Arabia's Ministry of Health (MOH) reported a new MERS-CoV case today in the capital city of Riyadh.
The case involves a 21-year-old Saudi woman who is in critical condition with a MERS-CoV (Middle East respiratory syndrome coronavirus) infection. She is not a healthcare worker and was not exposed to other MERS patients, the agency said. No other risk factors were noted.
Mapp Biopharmaceuticals announced yesterday that its experimental Ebola treatment ZMapp received fast-track status to gain US Food and Drug Administration (FDA) approval.
Temporary poultry market closures can drop environmental levels of H7N9 and other avian flu viruses, but after stalls reopen, contamination quickly returns to preclosure levels, Chinese researchers reported yesterday in Emerging Infectious Diseases.
The study took place in Guangzhou, the largest city in southern China's Guangdong province, during the second wave of human illnesses.
The World Health Organization (WHO) said today that it and partner groups working on earthquake response in Nepal are deploying extra medications and equipment to prevent the spread of diarrheal diseases such as cholera, which can spread when disasters damage and contaminate the clean water supply.
Groups estimate that at least 2.8 million people have been displaced, with many living in 16 makeshift camps.
Health officials in Ohio have confirmed botulism as the illness that sickened several people and killed one who attended the same church lunch in Lancaster, Ohio, on Apr 19, the Lancaster Eagle-Gazette reported on Apr 25.
Two common antibiotics used for serious skin infections—clindamycin and trimethoprim sulfamethoxazole (TMP-SMX) —both had about an 80% success rate in curing uncomplicated methicillin-resistant Staphylococcus aureus (MRSA) skin infections, according to a study today in the New England Journal of Medicine (NEJM).
A 72-year-old Saudi woman has died of MERS-CoV in Buraydah, and a previously reported MERS patient has also died, the country's Ministry of Health (MOH) said today as a top official noted more international help with the outbreak.
The median duration of colonization with community-based methicillin-resistant Staphylococcus aureus (MRSA) in ambulatory patients is 21 days, shorter than the previously thought duration of 6 to 9 months, and treatment with clindamycin is associated with more rapid clearance of the infection, say findings of a study published yesterday in Clinical Infectious Diseases.
Findings presented at a major infectious disease conference in Philadelphia today suggest that hospital antibiotic stewardship programs can pay unexpected benefits in children.
